Anti-Mi-2 antibodies
- 1 February 2005
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 38 (1) , 79-83
- https://doi.org/10.1080/08916930400022681
Abstract
Autoantibodies targeting the Mi-2 nuclear antigen represent one of the serologic hallmarks of idiopathic inflammatory myopathies, with a diagnostic sensitivity and specificity of approximately 4-18% and 98-100%, respectively. Mi-2 antigen is a component of the nuclesome remodeling-deacetylase (NuRD) complex involved in transcription regulation.Anti-Mi-2 antibodies are strongly associated with dermatomyositis (frequency up to 31%) and have a very high positive predictive value for such disease subset. A strong correlation with HLA-DR7 has been demonstrated. At the moment, optimal serologic testing is achieved by ELISA screening on recombinant Mi-2 antigen and confirmation of positive results on immunoblot.Keywords
This publication has 3 references indexed in Scilit:
- Classification criteria for the idiopathic inflammatory myopathiesCurrent Opinion in Rheumatology, 1997
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- Description of a serological reaction characteristic of polymyositisClinical Immunology and Immunopathology, 1976